These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22475789)

  • 1. [Kidney injury biomarkers].
    Gueguen Y; Rouas C; Leblond FA
    Nephrol Ther; 2012 Jun; 8(3):146-55. PubMed ID: 22475789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel kidney injury biomarkers.
    Adler S
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S15-8. PubMed ID: 20797563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective.
    Tesch GH
    Nephrology (Carlton); 2010 Sep; 15(6):609-16. PubMed ID: 20883281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
    Roels HA; Hoet P; Lison D
    Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of impaired renal function.
    Post FA; Wyatt CM; Mocroft A
    Curr Opin HIV AIDS; 2010 Nov; 5(6):524-30. PubMed ID: 20978396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of congenital obstructive nephropathy: past, present and future.
    Chevalier RL
    J Urol; 2004 Sep; 172(3):852-7. PubMed ID: 15310982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific biomarkers in renal medicine and research.
    Shaw M
    Methods Mol Biol; 2010; 641():271-302. PubMed ID: 20407953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biomarkers in diagnosis of kidney diseases caused by chemical toxins].
    Lutz W; Krajewska B
    Med Pr; 1997; 48(2):205-13. PubMed ID: 9273443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent successes in the identification, development, and qualification of translational biomarkers: the next generation of kidney injury biomarkers.
    Ennulat D; Adler S
    Toxicol Pathol; 2015 Jan; 43(1):62-9. PubMed ID: 25492424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
    Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for kidney diseases: older measures versus novel biomarkers.
    Wu I; Parikh CR
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1895-901. PubMed ID: 18922990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary mercury and biomarkers of early renal dysfunction in environmentally and occupationally exposed adults: a three-country study.
    Jarosińska D; Horvat M; Sällsten G; Mazzolai B; Dabkowska B; Prokopowicz A; Biesiada M; Barregård L
    Environ Res; 2008 Oct; 108(2):224-32. PubMed ID: 18684440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid-binding protein as marker for renal injury.
    Pelsers MM
    Scand J Clin Lab Invest Suppl; 2008; 241():73-7. PubMed ID: 18569970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of renal effects in children and adults with low environmental exposure to heavy metals.
    de Burbure C; Buchet JP; Bernard A; Leroyer A; Nisse C; Haguenoer JM; Bergamaschi E; Mutti A
    J Toxicol Environ Health A; 2003 May; 66(9):783-98. PubMed ID: 12746126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic potential of urine proteome: a broken mirror of renal diseases.
    Goligorsky MS; Addabbo F; O'Riordan E
    J Am Soc Nephrol; 2007 Aug; 18(8):2233-9. PubMed ID: 17625117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database.
    Kondo C; Minowa Y; Uehara T; Okuno Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2009 Nov; 265(1-2):15-26. PubMed ID: 19761811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTIS: use of combined biomarkers for providing diagnostic information on disease states.
    Hofmann W; Sedlmeir-Hofmann C; Ivandić M; Ruth D; Luppa P
    Methods Mol Biol; 2010; 641():123-42. PubMed ID: 20407945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of heart and kidney biomarkers to the pathogenesis of cardiorenal syndrome].
    Gai JJ; Gai LY; Liu HB; Wang ZG; Chen L; Sun ZJ; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1122-6. PubMed ID: 20501410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.
    Spasovski G; Ortiz A; Vanholder R; El Nahas M
    Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.